Price $17.81 |
Market Cap
113.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
9.9
|
P/B
0.75
|
P/S
1.16
|
Dividend %
-
|
|
P/CF
27.1
|
P/FCF
10.7
|
Op. Cash Flow
15.3K
|
FCF
1.5
|
|
Op. Margin
22.60%
|
Net Margin
12.00%
|
ROE
8.00%
|
ROI
10.90%
|
|
ROA
6.00%
|
EPS Growth
21.00%
|
Current Ratio
7.1
|
Debt/Equity
0.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| RegeneRx Biopharmaceuticals In (RGRX) | $0.16 | - | - | 21.5M | Strong Buy |
| Streamline Health Solutions In (STRM) | $1.91 | - | - | 86.4M | Strong Buy |
| Star Equity Holdings Inc (STRR) | $0.96 | - | - | 15.8M | Strong Buy |
| HTG Molecular Diagnostics Inc (HTGM) | $0.24 | - | - | 5.3M | Strong Buy |
| Helius Medical Technologies In (HSDT) | $0.26 | - | - | 7.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
